Seek truth from facts, competitive symbiosis
Hunan Zhengqing Pharmaceutical Group Co., Ltd. 2024 First Extraordinary General Meeting of Shareholders Resolution Announcement
Category:
Release time:
2024-07-19
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
20 Announcement of Resolutions from the First Extraordinary General Meeting of Shareholders in 2024
I. Meeting Convocation and Attendance
Time of Convocation: 20 July 17, 2024, 9:30 AM
Meeting Venue: Huaihua, Hunan High-tech Development Zone Caifu Road 7 No. [Number] Company Fifth Floor Meeting Room
Method of Convocation: In-person
Meeting Convener: Board of Directors
Meeting Chairman: Chairman Wu Feichi
The total number of shareholders and shareholder representatives attending this general meeting was 12 persons, holding voting rights of 118,667,521 shares, accounting for [percentage] of the company's total shares. 58.09%。
II. Review of Proposals
This meeting reviewed one proposal, specifically as follows:
1. "Proposal on Repurchasing Company Shares" (Regarding this proposal, related shareholders Hunan Xiangjiang Liyuan Zhenghong Venture Capital Partnership (Limited Partnership) and Huang Bingxian abstained from voting)
Voting Result: The proposal reviewed at this meeting was approved, receiving the consent of two-thirds of the total effective voting shares held by the shareholders attending the meeting.
III. Lawyer's Attestation
This general meeting of shareholders was attested by lawyers Liu Zhongming and Zhang Yingqi from Hunan Qiyuan Law Firm, who issued legal opinions stating that the convocation and holding procedures, qualifications of attendees, voting procedures, and voting results of this general meeting were legal and valid.
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
20 July 19, 2024
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地